Myeloma Tumor Cell Growth And Survival Regulated By Human C-Reactive Protein

Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.CRP is a protein that is made in the liver and secreted systemically during the process of inflammation in response to the inflammatory cytokine IL-6. [click link for full article]

More: continued here

Filed under: Cancer on September 13th, 2007